1. Home
  2. FDMT vs PDT Comparison

FDMT vs PDT Comparison

Compare FDMT & PDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo 4D Molecular Therapeutics Inc.

FDMT

4D Molecular Therapeutics Inc.

N/A

Current Price

$10.21

Market Cap

695.3M

Sector

Health Care

ML Signal

N/A

Logo John Hancock Premium Dividend Fund

PDT

John Hancock Premium Dividend Fund

N/A

Current Price

$11.55

Market Cap

581.9M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
FDMT
PDT
Founded
2013
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance Companies
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
695.3M
581.9M
IPO Year
2019
1994

Fundamental Metrics

Financial Performance
Metric
FDMT
PDT
Price
$10.21
$11.55
Analyst Decision
Strong Buy
Analyst Count
12
0
Target Price
★ $28.09
N/A
AVG Volume (30 Days)
★ 855.5K
136.0K
Earning Date
11-12-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
★ 18.79
N/A
EPS
N/A
★ N/A
Revenue
★ $85,209,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$20.79
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 230194.60
N/A
52 Week Low
$6.96
$11.49
52 Week High
$16.93
$13.65

Technical Indicators

Market Signals
Indicator
FDMT
PDT
Relative Strength Index (RSI) 37.51 32.10
Support Level $8.43 $11.49
Resistance Level $10.61 $13.02
Average True Range (ATR) 0.85 0.17
MACD -0.15 -0.05
Stochastic Oscillator 1.07 1.34

Price Performance

Historical Comparison
FDMT
PDT

About FDMT 4D Molecular Therapeutics Inc.

4D Molecular Therapeutics Inc is biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. Companies focus is on advancing 4D-150 for wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME) through late-stage studies. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-710 and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector).

About PDT John Hancock Premium Dividend Fund

John Hancock Premium Div Fund is a United States-based closed-end management investment company. It seeks to provide a high current income consistent with modest capital growth. The fund will pursue its objective by investing in a diversified portfolio comprised of dividend-paying preferred securities and common equity securities. The portfolio composition of the fund consists of preferred securities, common stocks, corporate bonds, capital preferred securities, and short-term investments.

Share on Social Networks: